Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine vs Azathioprine in Chronic Refractory Urticaria
NCT03250143Phase 2Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Dec 2016
- Primary completion
- Nov 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in chronic spontaneous urticaria (CSU) comparing Cyclosporine with Azathioprine (2 arms). Primary endpoint: Urticaria Activity Score 7 at 12 weeks. Started Dec 2016; status: completed.
02
Drugs
cyclosporineazathioprine
03
Conditions
chronic spontaneous urticaria (CSU)
Beyond the preview
Go deeper on NCT03250143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03250143.